How to Use Budesonide/Formoterol as Reliever Therapy
For adults and adolescents ≥12 years with asthma, use budesonide/formoterol as reliever therapy by taking one inhalation as needed for symptom relief, up to a maximum of 12 total inhalations per day (including maintenance doses), which provides both immediate bronchodilation and anti-inflammatory treatment with each use. 1
Dosing Regimen
Standard SMART (Single Maintenance and Reliever Therapy) Protocol
- Maintenance dosing: Take budesonide/formoterol 160/4.5 mcg, one inhalation once or twice daily for Step 3 asthma, or two inhalations twice daily for Step 4 asthma 1
- Reliever dosing: Take one additional inhalation of budesonide/formoterol 160/4.5 mcg whenever you experience asthma symptoms 1
- Maximum daily limit: Do not exceed 12 total inhalations in any single day (delivering 54 mcg formoterol total) 1
Proper Inhalation Technique
- Shake the inhaler well for 5 seconds immediately before each use 2
- Remove the mouthpiece cover and check for foreign objects 2
- Breathe out fully, place the mouthpiece in your mouth with lips sealed around it 2
- Press down firmly on the counter while breathing in deeply and slowly 2
- Hold your breath for about 10 seconds after inhalation 2
- For two puffs, shake again for 5 seconds between inhalations 2
- Rinse your mouth with water and spit it out after each dose to reduce thrush risk 2
Key Advantages of This Approach
The budesonide/formoterol reliever strategy reduces severe asthma exacerbations by 46% compared to standard SABA reliever therapy (relative rate 0.54), while delivering anti-inflammatory medication precisely when symptoms occur. 3
- Formoterol provides rapid bronchodilation similar to albuterol, with onset suitable for symptom relief 1
- Each reliever dose delivers inhaled corticosteroid to address the underlying inflammation driving symptoms 4
- This approach reduces oral corticosteroid exposure despite slightly higher inhaled corticosteroid use 3
- Patients have fewer days of high β-agonist use without medical review compared to SABA-only regimens 3
Important Safety Considerations
What This Medication Does NOT Do
- Budesonide/formoterol is NOT a rescue inhaler for sudden severe symptoms - you still need a separate short-acting bronchodilator (like albuterol) for emergency situations 2
- Do not use other LABA-containing medications while on this regimen 2
When to Seek Medical Attention
Call your healthcare provider or seek emergency care if: 2
- Your breathing problems worsen despite using budesonide/formoterol
- You need more than the usual number of reliever inhalations
- Your symptoms don't improve after one week of regular use
- You experience chest pain, fast/irregular heartbeat, or severe tremor
Clinical Context and Evidence Quality
The SMART approach is supported by multiple high-quality randomized controlled trials in adults and adolescents ≥12 years. 1 The evidence demonstrates that this single-inhaler strategy reduces exacerbations while simplifying treatment by eliminating the need for separate controller and reliever inhalers. 5
A critical limitation: Most SMART trials used budesonide/formoterol specifically; other ICS/LABA combinations have not been adequately studied for this indication. 1 The FDA-approved budesonide/formoterol product should be used rather than attempting this approach with other combination inhalers.
Age Restrictions
- Approved for ages ≥12 years: Strong evidence supports use in adults and adolescents 1
- Not recommended for ages 5-11 years: Insufficient evidence in this age group 6
- Not studied in children <5 years: No data available 6
Monitoring and Follow-up
- Track your daily inhaler use - the counter on top shows remaining doses 2
- Discard the inhaler when the counter reaches zero or 3 months after opening the foil pouch, whichever comes first 2
- Regular follow-up appointments are essential to ensure the regimen remains appropriate for your asthma severity 6
- If you consistently need more than 8 reliever inhalations per day (beyond maintenance doses), contact your healthcare provider as this indicates inadequate control 3